{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T23:27:45Z","timestamp":1793921265401,"version":"4.8.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.diabres.2026.113581","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:46:27Z","timestamp":1790264787000},"page":"113581","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Hemoglobinopathies and diabetes mellitus: from pathophysiology to clinical practice"],"prefix":"10.1016","volume":"241","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9844-2813","authenticated-orcid":false,"given":"Konstantinos","family":"Manganas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelia","family":"Tzeravini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Delicou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5897-472X","authenticated-orcid":false,"given":"Anastasios","family":"Tentolouris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2026.113581_b0005","doi-asserted-by":"crossref","first-page":"a011692","DOI":"10.1101\/cshperspect.a011692","article-title":"World distribution, population genetics, and health burden of the hemoglobinopathies","volume":"2","author":"Williams","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.diabres.2026.113581_b0010","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1111\/bjh.20043","article-title":"Comparative analysis of mortality patterns and treatment strategies in thalassaemia and sickle cell disease patients: a 12\u2010year study","volume":"206","author":"Delicou","year":"2025","journal-title":"Br J Haematol"},{"key":"10.1016\/j.diabres.2026.113581_b0015","doi-asserted-by":"crossref","first-page":"16263","DOI":"10.3390\/ijms242216263","article-title":"Endocrinopathies in hemoglobinopathies: what is the Role of Iron?","volume":"24","author":"Evangelidis","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.diabres.2026.113581_b0020","first-page":"403","article-title":"Non-transferrin bound iron: a key role in iron overload and iron toxicity","volume":"2012","author":"Brissot","year":"1820","journal-title":"Biochim Biophys Acta BBA \u2013 Gen Subj"},{"key":"10.1016\/j.diabres.2026.113581_b0025","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.3390\/cells10112841","article-title":"Iron metabolism in pancreatic beta-cell function and dysfunction","volume":"10","author":"Marku","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.diabres.2026.113581_b0030","article-title":"The role of metal ion metabolism in the pathogenesis of diabetes and associated complications","volume":"16","author":"Liu","year":"2025","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.diabres.2026.113581_b0035","doi-asserted-by":"crossref","first-page":"13782","DOI":"10.3390\/ijms241813782","article-title":"Mitochondrial dynamics and insulin secretion","volume":"24","author":"Kabra","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.diabres.2026.113581_b0040","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70268","article-title":"Oxidative stress: signaling pathways, biological functions, and disease","volume":"6","author":"Liu","year":"2025","journal-title":"MedComm"},{"key":"10.1016\/j.diabres.2026.113581_b0045","doi-asserted-by":"crossref","first-page":"R33","DOI":"10.1530\/JME-15-0232","article-title":"Oxidative and endoplasmic reticulum stress in \u03b2-cell dysfunction in diabetes","volume":"56","author":"Hasnain","year":"2016","journal-title":"J Mol Endocrinol"},{"key":"10.1016\/j.diabres.2026.113581_b0050","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/1930261","article-title":"Oxidative stress in pancreatic beta cell regeneration","volume":"2017","author":"Wang","year":"2017","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.diabres.2026.113581_b0055","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00431-002-1121-7","article-title":"Insulin sensitivity and \u03b2-cell secretion in thalassaemia major with secondary haemochromatosis: assessment by oral glucose tolerance test","volume":"162","author":"Cario","year":"2003","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.diabres.2026.113581_b0060","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3390\/antiox10020296","article-title":"Sickle cell disease: role of oxidative stress and antioxidant therapy","volume":"10","author":"Vona","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.diabres.2026.113581_b0065","doi-asserted-by":"crossref","first-page":"21525","DOI":"10.3390\/ijms141121525","article-title":"Oxidative stress in diabetes: implications for vascular and other complications","volume":"14","author":"Pitocco","year":"2013","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.diabres.2026.113581_b0070","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3389\/fphys.2018.00125","article-title":"Erythrocytes and vascular function: oxygen and nitric oxide","volume":"9","author":"Helms","year":"2018","journal-title":"Front Physiol"},{"key":"10.1016\/j.diabres.2026.113581_b0075","doi-asserted-by":"crossref","first-page":"456","DOI":"10.3181\/00379727-216-44197","article-title":"Heme induces the expression of adhesion molecules ICAM-1, VCAM-1, and E selectin in vascular endothelial cells","volume":"216","author":"Wagener","year":"1997","journal-title":"Exp Biol Med"},{"key":"10.1016\/j.diabres.2026.113581_b0080","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.3389\/fimmu.2020.01964","article-title":"TLR4 signaling by heme and the role of heme-binding blood proteins","volume":"11","author":"Janciauskiene","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.diabres.2026.113581_b0085","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.2147\/DMSO.S236127","article-title":"The role of JNk signaling pathway in obesity-driven insulin resistance","volume":"13","author":"Feng","year":"2020","journal-title":"Diabetes Metab Syndr Obes Targets Ther"},{"key":"10.1016\/j.diabres.2026.113581_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/mmr.2025.13773","article-title":"Influence and treatment of insulin receptor substrate\/PI3K\/Akt\u2011mediated insulin resistance in diabetes mellitus (Review)","volume":"33","author":"Tang","year":"2025","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.diabres.2026.113581_b0095","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.3390\/biom15121745","article-title":"Insulin resistance at the crossroads of metabolic inflammation, cardiovascular disease, organ failure and cancer","volume":"15","author":"Lonardo","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.diabres.2026.113581_b0100","doi-asserted-by":"crossref","first-page":"10105","DOI":"10.1074\/jbc.M600272200","article-title":"FoxO1 regulates multiple metabolic pathways in the liver","volume":"281","author":"Zhang","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.diabres.2026.113581_b0105","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/bjh.18548","article-title":"Sickle cell disease implementation consortium, characterising the prevalence of overweight and obese status among adults with sickle cell disease","volume":"200","author":"Ibemere","year":"2023","journal-title":"Br J Haematol"},{"key":"10.1016\/j.diabres.2026.113581_b0110","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.27985","article-title":"Nutritional status in a sample of patients with \u03b2-thalassemia major","author":"Lidoriki","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.diabres.2026.113581_b0115","article-title":"G6PD deficiency and hemoglobinopathies: molecular epidemiological characteristics and healthy effects on malaria endemic Bioko Island, Equatorial Guinea","volume":"10","author":"Lin","year":"2015","journal-title":"PLOS ONE"},{"key":"10.1016\/j.diabres.2026.113581_b0120","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s44324-025-00061-6","article-title":"Clinical associations and potential cellular mechanisms linking G6PD deficiency and atherosclerotic cardiovascular disease","volume":"3","author":"Andrews","year":"2025","journal-title":"NPJ Metab Health Dis"},{"key":"10.1016\/j.diabres.2026.113581_b0125","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.2337\/dc11-2527","article-title":"Glucose-6-phosphate dehydrogenase deficiency and type 2 diabetes","volume":"35","author":"Heymann","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2026.113581_b0130","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1056\/NEJMc2406156","article-title":"Type 2 diabetes in patients with G6PD deficiency","volume":"391","author":"Israel","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2026.113581_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2021.e06443","article-title":"Da Costa Escobar Piccoli, Association between carriers of the G allele of the + 45T> G variant of the ADIPOQ gene (rs 2241766) and the cardiometabolic profile in sickle cell trait","author":"Bruno","year":"2021","journal-title":"Heliyon 7"},{"key":"10.1016\/j.diabres.2026.113581_b0140","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee for Diabetes*, Bajaj M, McCoy RG, Balapattabi K, Bannuru RR, Bellini NJ, et al. 2. Diagnosis and classification of diabetes: standards of care in diabetes\u20142026, Diabetes Care 2026;49:S27\u201349. Doi: 10.2337\/dc26-S002.","DOI":"10.2337\/dc26-S002"},{"key":"10.1016\/j.diabres.2026.113581_b0145","doi-asserted-by":"crossref","DOI":"10.1002\/hem3.70095","article-title":"TIF guidelines for the management of transfusion\u2010dependent \u03b2\u2010thalassemia","volume":"9","author":"Musallam","year":"2025","journal-title":"HemaSphere"},{"key":"10.1016\/j.diabres.2026.113581_b0150","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3343\/alm.2013.33.6.393","article-title":"HbA1c: a review of analytical and clinical aspects","volume":"33","author":"Weykamp","year":"2013","journal-title":"Ann Lab Med"},{"key":"10.1016\/j.diabres.2026.113581_b0155","doi-asserted-by":"crossref","first-page":"707","DOI":"10.3892\/etm.2022.11643","article-title":"Interpretation of HbA1c lies at the intersection of analytical methodology, clinical biochemistry and hematology (Review)","volume":"24","author":"Chen","year":"2022","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.diabres.2026.113581_b0160","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1177\/193229680900300307","article-title":"A review of variant hemoglobins interfering with hemoglobin A1c measurement","volume":"3","author":"Little","year":"2009","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.diabres.2026.113581_b0165","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1001\/jama.2017.4643","article-title":"Measurement of hemoglobin A1c in patients with sickle cell trait","volume":"317","author":"Rohlfing","year":"2017","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.diabres.2026.113581_b0170","doi-asserted-by":"crossref","first-page":"8635","DOI":"10.1021\/ac301756d","article-title":"Detection of total and A1c-glycosylated hemoglobin in human whole blood using sandwich immunoassays on polydimethylsiloxane-based antibody microarrays","volume":"84","author":"Chen","year":"2012","journal-title":"Anal Chem"},{"key":"10.1016\/j.diabres.2026.113581_b0175","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1373\/clinchem.2018.296962","article-title":"The national glycohemoglobin standardization program: over 20 years of improving hemoglobin A1c measurement","volume":"65","author":"Little","year":"2019","journal-title":"Clin Chem"},{"key":"10.1016\/j.diabres.2026.113581_b0180","doi-asserted-by":"crossref","first-page":"233","DOI":"10.5455\/aim.2016.24.233-238","article-title":"Glycated hemoglobin (HbA1c): clinical applications of a mathematical concept","volume":"24","author":"Leow","year":"2016","journal-title":"Acta Inform Medica"},{"key":"10.1016\/j.diabres.2026.113581_b0185","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1630994","article-title":"Sickle cell disease: understanding pathophysiology, clinical features and advances in gene therapy approaches","volume":"16","author":"Taher","year":"2025","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.diabres.2026.113581_b0190","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/1932296819841698","article-title":"Hemoglobinopathies and hemoglobin A1c in diabetes mellitus","volume":"14","author":"Klonoff","year":"2020","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.diabres.2026.113581_b0195","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.73236","article-title":"Estimation of HbA1c levels in transfusion-dependent thalassemia patients in comparison with normal healthy individuals","author":"Bhatti","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.diabres.2026.113581_b0200","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1177\/1932296814567227","article-title":"Advantages and pitfalls of fructosamine and glycated albumin in the diagnosis and treatment of diabetes","volume":"9","author":"Danese","year":"2015","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.diabres.2026.113581_b0205","doi-asserted-by":"crossref","DOI":"10.4084\/mjhid.2016.058","article-title":"The ICET-A recommendations for the diagnosis and management of disturbances of glucose homeostasis in thalassemia major patients","volume":"8","author":"De Sanctis","year":"2016","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10.1016\/j.diabres.2026.113581_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.108918","article-title":"Serum fructosamine and glycemic status in the presence of the sickle cell mutation","volume":"177","author":"Doumatey","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabres.2026.113581_b0215","article-title":"Glycated albumin percentage is correlated with HbA1c: theoretic marker in patients with altered erythrocyte turnover","author":"G\u00e5fvels","year":"2025","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.diabres.2026.113581_b0220","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13098-025-01591-1","article-title":"Novel indicator of microvascular complications in patients with type 2 diabetes mellitus and shortened erythrocyte lifespan: a multicenter cross-sectional analysis","volume":"17","author":"Wu","year":"2025","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/j.diabres.2026.113581_b0225","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1111\/dom.16279","article-title":"Time in range\u2014a new gold standard in type 2 diabetes research?","volume":"27","author":"Goshrani","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.diabres.2026.113581_b0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2025.112076","article-title":"Characterisation of transfusion-dependent prediabetes using continuous glucose monitoring: the Haemoglycare study","volume":"222","author":"Zanfardino","year":"2025","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabres.2026.113581_b0235","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/ajh.24858","article-title":"Individuals with sickle cell disease have a significantly greater vasoconstriction response to thermal pain than controls and have significant vasoconstriction in response to anticipation of pain","volume":"92","author":"Khaleel","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1016\/j.diabres.2026.113581_b0240","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1177\/19322968211065065","article-title":"Interferences with CGM systems: practical relevance?","volume":"16","author":"Heinemann","year":"2022","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.diabres.2026.113581_b0245","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1177\/1932296818821389","article-title":"Comparative accuracy evaluation of a blood glucose meter with novel hematocrit correction technology, with three currently used commercially available blood glucose monitoring systems","volume":"13","author":"Dunseath","year":"2019","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.diabres.2026.113581_b0250","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1177\/193229680900300438","article-title":"Factors affecting blood glucose monitoring: sources of errors in measurement","volume":"3","author":"Ginsberg","year":"2009","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.diabres.2026.113581_b0255","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3747\/pdi.2008.00285","article-title":"False elevation of blood glucose levels measured by GDH-PQQ-BASED glucometers occurs during all daily dwells in peritoneal dialysis patients using icodextrin","volume":"30","author":"Tsai","year":"2010","journal-title":"Perit Dial Int J Int Soc Perit Dial"},{"key":"10.1016\/j.diabres.2026.113581_b0260","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee for Diabetes*, Bajaj M, McCoy RG, Balapattabi K, Bannuru RR, Bellini NJ, et al. 9. Pharmacologic approaches to glycemic treatment: standards of care in diabetes\u20142026, Diabetes Care 2026;49:S183\u2013215. Doi: 10.2337\/dc26-S009.","DOI":"10.2337\/dc26-S009"},{"key":"10.1016\/j.diabres.2026.113581_b0265","article-title":"The the use of oral glucose-lowering agents (GLAs) in \u03b2-thalassemia patients with diabetes: preliminary data from a retrospective study of ICET-A Network: Oral glucose-lowering agents (GLAs) in \u03b2-thalassemia patients","volume":"93","author":"De Sanctis","year":"2022","journal-title":"Acta Biomed Atenei Parm"},{"key":"10.1016\/j.diabres.2026.113581_b0270","doi-asserted-by":"crossref","DOI":"10.4084\/mjhid.2017.004","article-title":"Effectiveness and safety of sitagliptin in patients with beta-thalassaemia major and diabetes mellitus: a case series","volume":"9","author":"Zonoozi","year":"2016","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10.1016\/j.diabres.2026.113581_b0275","article-title":"Oxidative stress and inflammatory markers in prediabetes and diabetes","author":"Luc","year":"2019","journal-title":"J Physiol Pharmacol"},{"key":"10.1016\/j.diabres.2026.113581_b0280","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"DAPA-CKD trial committees and investigators, dapagliflozin in patients with chronic kidney disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2026.113581_b0285","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa2204233","article-title":"Empagliflozin in patients with chronic kidney disease","volume":"388","author":"The EMPA-KIDNEY Collaborative Group","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2026.113581_b0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000552285","article-title":"Dapagliflozin in patients with homozygous \u03b2-thalassemia and albuminuria","author":"Tsiotsios","year":"2026","journal-title":"Acta Haematol"},{"key":"10.1016\/j.diabres.2026.113581_b0295","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.69837","article-title":"Impact of empagliflozin on the outcomes of \u03b2-thalassemia major in patients with type 2 diabetes mellitus: the THALEMPA Observational Study","author":"Ibraheem","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.diabres.2026.113581_b0300","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1002\/ajh.27348","article-title":"GLP \u20101 agonists and SGLT \u20102 inhibitors in adults with sickle cell disease","volume":"99","author":"Sun","year":"2024","journal-title":"Am J Hematol"},{"key":"10.1016\/j.diabres.2026.113581_b0305","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/cvr\/cvag003","article-title":"Beneficial effects of SGLT1\/2 and SGLT2 inhibitors on vaso-occlusive events and organ damage in sickle cell disease mice","volume":"122","author":"Jin","year":"2026","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.diabres.2026.113581_b0310","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13023-026-04322-5","article-title":"Outcomes of GLP-1 receptor agonist therapy in adults with sickle cell disease and type 2 diabetes: a real-world cohort analysis","volume":"21","author":"Nguefang","year":"2026","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.diabres.2026.113581_b0315","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1365-2141.2006.06203.x","article-title":"Effect of enhanced iron chelation therapy on glucose metabolism in patients with \u03b2\u2010thalassaemia major","volume":"134","author":"Farmaki","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.diabres.2026.113581_b0320","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/ajh.23405","article-title":"Treating iron overload in patients with non\u2010transfusion\u2010dependent thalassemia","volume":"88","author":"Taher","year":"2013","journal-title":"Am J Hematol"},{"key":"10.1016\/j.diabres.2026.113581_b0325","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000450673","article-title":"Effect of iron chelation therapy on glucose metabolism in non-transfusion-dependent thalassaemia","volume":"137","author":"Chuansumrit","year":"2017","journal-title":"Acta Haematol"},{"key":"10.1016\/j.diabres.2026.113581_b0330","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1093\/ajcn\/61.3.582","article-title":"Resting energy expenditure in patients with thalassemia major","volume":"61","author":"Vaisman","year":"1995","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.diabres.2026.113581_b0335","doi-asserted-by":"crossref","unstructured":"Chen X, Qiu S, Jiang J, Wu Q. Beyond bones, vitamin D as a sunshine hormone in type 2 diabetes mellitus and its complications. iScience 2026;29:115153. Doi: 10.1016\/j.isci.2026.115153.","DOI":"10.1016\/j.isci.2026.115153"},{"key":"10.1016\/j.diabres.2026.113581_b0340","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1182\/hematology.2019000054","article-title":"A program of transition to adult care for sickle cell disease","volume":"2019","author":"Saulsberry","year":"2019","journal-title":"Hematology"},{"key":"10.1016\/j.diabres.2026.113581_b0345","doi-asserted-by":"crossref","DOI":"10.4084\/MJHID.2026.039","article-title":"Aging with thalassemia and sickle cell disease: a gerontological model of accelerated multimorbidity and function-centered care beyond midlife: thalassemia and sickle cell diseases: effect of aging","volume":"18","author":"Delicou","year":"2026","journal-title":"Mediterr J Hematol Infect Dis"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822726005012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822726005012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T23:22:21Z","timestamp":1793920941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822726005012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":69,"alternative-id":["S0168822726005012"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2026.113581","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hemoglobinopathies and diabetes mellitus: from pathophysiology to clinical practice","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2026.113581","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"113581"}}